Suppr超能文献

使用瑞必适疫苗接种和泰妙菌素治疗减少猪支原体肺炎造成的经济损失。

Reduction of economic losses caused by mycoplasmal pneumonia of pigs by vaccination with Respisure and by Tiamutin treatment.

作者信息

Stipkovits L, Laky Zs, Abonyi T, Siugzdaite Jurate, Szabó I

机构信息

Veterinary Medical Research Institute, Hungarian Academy of Sciences, H-1581 Budapest, PO Box 18, Hungary.

出版信息

Acta Vet Hung. 2003;51(3):259-71. doi: 10.1556/AVet.51.2003.3.2.

Abstract

The possibilities and economic benefits of controlling mycoplasmal pneumonia of pigs caused by Mycoplasma hyopneumoniae by immunisation with Respisure and by Tiamutin treatment were studied. The experiment was carried out in a herd comprising 1000 sows which was free of PRRS, Aujeszky's disease, swine dysentery and leptospirosis, and the prevalence of mycoplasmal pneumonia was low because the farm had recently been restocked. Groups C1 and C2 served as untreated controls, while Groups R1 and R2 received a prestarter diet containing 100 ppm Tiamutin from the time of weaning. Piglets of Group R1 were vaccinated with Respisure vaccine once on day 69, while those of Group R2 twice, on days 65 and 80. Piglets of Groups ST1 and ST2 were fed 100 ppm Tiamutin in the diet for 7 days at the time of weaning and then at 4 months of age, while pigs of Group ST2 received such treatment also in the 6th month of life. The efficacy of treatment was analysed on the basis of the number of animals that died, were emergency slaughtered or were retarded in growth in the different groups, the body weight of animals at weaning, at 94 and 148 days of age and at the time of slaughter, their daily body weight gain, the lung lesions found in animals slaughtered from the different groups, the costs of medication and vaccination, and the cost-benefit calculations of the results. The mortality and emergency slaughter rate was 2.88% and 4.62% in Groups ST2 and ST1, respectively, 4.23% and 4.62% in Groups R2 and R1, respectively, and 8.39% and 9.44% in the control groups (C2 and C1, respectively). The rate of growth retardation was 0.48% and 2.12% in Groups R1 and R2, respectively, 1.59% and 3.46% in Groups ST1 and ST2, respectively, as compared to 8.03% and 6.55% in the control groups (C1 and C2, respectively). The severity score of lung lesions was 1.82 and 1.46 in Groups R1 and R2, 2.18 and 2.93 in Groups ST1 and ST2, and 3.83 and 4.02 in the control groups C1 and C2, respectively. The mean finishing weight of pigs was 102.4-107.8 kg and 95.2-106.6 kg in the treated groups and 94.5-98.6 kg in the control groups. The classification of pigs according to the EUROP categories showed a shift to the E and U categories in the treated groups. The average feed cost per one kg of liveweight was 77.89-82.64 Forints in the treated groups and 85.66 Forints in the control groups.

摘要

研究了使用瑞必适疫苗免疫和泰妙菌素治疗控制猪肺炎支原体引起的猪支原体肺炎的可能性和经济效益。实验在一个有1000头母猪的猪群中进行,该猪群无猪繁殖与呼吸综合征、奥耶斯基氏病、猪痢疾和钩端螺旋体病,且由于该农场最近重新补栏,支原体肺炎的患病率较低。C1组和C2组作为未治疗对照组,而R1组和R2组从断奶时起接受含100 ppm泰妙菌素的开食前日粮。R1组仔猪在69日龄时用瑞必适疫苗接种一次,而R2组仔猪在65日龄和80日龄时接种两次。ST1组和ST2组仔猪在断奶时以及4月龄时在日粮中饲喂100 ppm泰妙菌素7天,而ST2组猪在6月龄时也接受这种治疗。根据不同组中死亡、紧急屠宰或生长受阻的动物数量、断奶时、94日龄和148日龄以及屠宰时动物的体重、它们的日体重增加、不同组屠宰动物中发现的肺部病变、药物治疗和疫苗接种成本以及结果的成本效益计算来分析治疗效果。ST2组和ST1组的死亡率和紧急屠宰率分别为2.88%和4.62%,R2组和R1组分别为4.23%和4.62%,对照组(分别为C2组和C1组)为8.39%和9.44%。与对照组(分别为C1组和C2组)的8.03%和6.55%相比,R1组和R2组的生长受阻率分别为0.48%和2.12%,ST1组和ST2组分别为1.59%和3.46%。R1组和R2组肺部病变的严重程度评分为1.82和1.46,ST1组和ST2组为2.18和2.93,对照组C1组和C2组为3.83和4.02。治疗组猪的平均育肥体重为102.4 - 107.8千克和95.2 - 106.6千克,对照组为94.5 - 98.6千克。根据欧盟ROP分类对猪进行分类显示,治疗组向E类和U类转变。治疗组每千克活重的平均饲料成本为77.89 - 82.64福林,对照组为85.66福林。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验